Blue Horizon is a private equity firm focused on lower middle market buyouts and growth equity investments, where our operating experience
Blue Horizon is a private equity firm focused on lower middle market buyouts and growth equity investments, where our operating experience adds significant value.Our team has outstanding investing and management track records and expertise across a broad range of industry sectors and transaction structures. We offer clear advantages in achieving superior risk-adjusted returns given our deep operating expertise, active executive network and flexible investment mandate. Blue Horizon invests across multiple industry sectors, including, but not limited to, Consumer Products, Business Services, Technology, Health/Wellness and Environmental Sustainability. Target companies exhibit high growth potential, low capital intensity, and have $5 million to $100 million in revenue and positive cash flow.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 30, 2022
Core Biogenesis
|
Series A | $11M | Biotechnology | Yes |
Jun 20, 2018
Finless Foods
|
Seed | $3.50M | Consumer Goods | — |